| [1] |
Dressman HK, Hans C, Bild A, et al. Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy [J]. Clin Cancer Res, 2006, 12(3 Pt 1): 819-826.
|
| [2] |
Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast tumors [J]. Nature, 2000, 406(6797): 747-752.
|
| [3] |
Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 [J]. Ann Oncol, 2011, 22(8): 1736-1747.
|
| [4] |
Groheux D, Giacchetti S, Hatt M, et al. HER2-overexpressing breast cancer: FDG uptake after two cycles of chemotherapy predicts the outcome of neoadjuvant treatment [J]. Br J Cancer, 2013, 109(5): 1157-1164.
|
| [5] |
Goldhirsch A, Winer EP, Coates AS, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 [J]. Ann Oncol, 2013, 24(9): 2206-2223.
|
| [6] |
Shim HJ, Kim SH, Kang BJ, et al. Breast cancer recurrence according to molecular subtype [J]. Asian Pac J Cancer Prev, 2014, 15(14): 5539-5544.
|
| [7] |
袁中玉, 王树森, 朱美琴, 等. 不同分子亚型乳腺癌的临床特征和预后[J]. 中华肿瘤杂志, 2008, 30(6): 456-461.
|
| [8] |
Voduc KD, Cheang MC, Tyldesley S, et al. Breast cancer subtypes and the risk of local and regional relapse [J]. J Clin Oncol, 2010, 28(10): 1684-1691.
|
| [9] |
Kennecke H, Yerushalmi R, Woods R, et al. Metastatic behavior of breast cancer subtypes [J]. J Clin Oncol, 2010, 28(20): 3271-3277.
|
| [10] |
Ribelles N, Perez-Villa L, Jerez JM, et al. Pattern of recurrence of early breast cancer is different according to intrinsic subtype and proliferation index [J]. Breast Cancer Res, 2013, 15(5): R98.
|
| [11] |
彭艳华. 乳腺癌分子分型与远处转移时间及部位的分析[D]. 广州医学院, 2010.
|
| [12] |
Lowery AJ, Kell MR, Glynn RW, et al. Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype [J]. Breast Cancer Res Treat, 2012, 133(3): 831-841.
|
| [13] |
Yilmaz MH, Esen G, Ayarcan Y, et al. The role of US and MR imaging in detecting local chest wall tumor recurrence after mastectomy [J]. Diagn Interv Radiol, 2007, 13(1): 13-18.
|
| [14] |
Lee KA, Jochelson MS. Post breast conservation therapy imaging and local recurrence [J]. Q J Nucl Med Mol Imaging, 2013, 57(4): 332-339.
|
| [15] |
Kim HJ, Kwak JY, Choi JW, et al. Impact of US surveillance on detection of clinically occult locoregional recurrence after mastectomy for breast cancer [J]. Ann Surg Oncol, 2010, 17(10): 2670-2676.
|
| [16] |
杨倩, 朱庆莉, 姜玉新, 等. 乳腺癌改良根治术后局部胸壁复发的临床特征与超声表现 [J/CD]. 中华医学超声杂志:电子版, 2013,10(8): 656-661.
|
| [17] |
Gunther-Tritsch K, Bojahr B, Ohlinger R. Diagnostic value of palpation and ultrasonography for diagnosing breast cancer recurrence after mastectomy--a comparison [J]. Ultraschall Med, 2009, 30(6): 577-584.
|
| [18] |
Khatcheressian JL, Hurley P, Bantug E, et al. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update [J]. J Clin Oncol, 2013, 31(7): 961-965.
|
| [19] |
Yoon JH, Kim MJ, Kim E-K, et al. Imaging Surveillance of Patients with Breast Cancer after Primary Treatment: Current Recommendations [J]. Korean J Radiol, 2015, 16(2): 219-228.
|
| [20] |
Belli P, Costantini M, Romani M, et al. Magnetic resonance imaging in breast cancer recurrence [J]. Breast Cancer Res Treat, 2002, 73(3): 223-235.
|
| [21] |
Lee HW, Kim SH. Breast Magnetic Resonance Imaging for Assessment of Internal Mammary Lymph Node Status in Breast Cancer [J]. J Breast Cancer, 2016, 19(2): 191-198.
|
| [22] |
Zhang X, Wu F, Han P. The role of (18)F-FDG PET/CT in the diagnosis of breast cancer and lymph nodes metastases and micrometastases may be limited [J]. Hell J Nucl Med, 2014, 17(3): 177-183.
|
| [23] |
Gaeta CM, Vercher-Conejero JL, Sher AC, et al. Recurrent and metastatic breast cancer PET, PET/CT, PET/MRI: FDG and new biomarkers [J]. Q J Nucl Med Mol Imaging, 2013, 57(4): 352-366.
|
| [24] |
Chikarmane SA, Tirumani SH, Howard SA, et al. Metastatic patterns of breast cancer subtypes: what radiologists should know in the era of personalized cancer medicine [J]. Clin Radiol, 2015, 70(1): 1-10.
|
| [25] |
Costelloe CM, Rohren EM, Madewell JE, et al. Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis [J]. Lancet Oncol, 2009, 10(6): 606-614.
|
| [26] |
Walker R, Kessar P, Blanchard R, et al. Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: Preliminary clinical experience [J]. J Magn Reson Imaging, 2000, 11(4): 343–350.
|
| [27] |
Engelhard K, Hollenbach HP, Wohlfart K, et al. Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer [J]. Eur Radiol, 2004, 14(1): 99-105.
|
| [28] |
Colzani E, Johansson AL, Liljegren A, et al. Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics [J]. Br J Cancer, 2014, 110(5): 1378-1384.
|
| [29] |
Cadoo KA, Fornier MN, Morris PG. Biological subtypes of breast cancer: current concepts and implications for recurrence patterns [J]. Q J Nucl Med Mol Imaging, 2013, 57(4): 312-321.
|
| [30] |
李小平, 黄雯霞, 刘鲁明. 乳腺癌肝转移诊断和治疗现状[J]. 临床肿瘤学杂志, 2003, 8(4): 299-301,308.
|
| [31] |
Brookes M, MacVicar D, Husband J. Metastatic carcinoma of the breast: the appearances of metastatic spread to the abdomen and pelvis as demonstrated by CT [J]. Br J Radiol, 2007, 80(952): 284-292.
|
| [32] |
Smid M, Wang Y, Zhang Y, et al. Subtypes of breast cancer show preferential site of relapse [J]. Cancer Res, 2008, 68(9): 3108-3114.
|
| [33] |
Jung JI, Kim HH, Park SH, et al. Thoracic manifestations of breast cancer and its therapy [J]. Radiographics, 2004, 24(5): 1269-1285.
|
| [34] |
Khatcheressian JL, Hurley P, Bantug E, et al. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update[J]. J Clin Oncol, 2012, 31(7): 961-965.
|
| [35] |
Sonnenblick A, Fumagalli D, Sotiriou C, et al. Is the differentiation into molecular subtypes of breast cancer important for staging, local and systemic therapy, and follow up? [J]. Cancer Treat Rev, 2014, 40(9): 1089-1095.
|